Adcendo ApS Announces U.S. FDA Clearance of IND Application for Phase I Tiffany-01 Trial of ADCE-T02
ADCE-T02 is a potential first-in-class Topoisomerase I inhibitor-based antibody-drug conjugate (ADC) targeting tissue factor, a validated ADC target overexpressed in multiple solid tumors Phase ...
In light of South Africa's ongoing energy crisis, REDISA advocates for urgent investments in waste-to-energy solutions.
1h
Hosted on MSNDanish investment firm buys Morecambe offshore wind projectCopenhagen Infrastructure Partners (CIP), on behalf of its fund Copenhagen Infrastructure V (CI V), has signed a transaction ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results